These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation. Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516 [TBL] [Abstract][Full Text] [Related]
6. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma. Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477 [TBL] [Abstract][Full Text] [Related]
7. Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation. Hansen MR; Linthicum FH Otol Neurotol; 2004 Mar; 25(2):155-9. PubMed ID: 15021776 [TBL] [Abstract][Full Text] [Related]
8. Treatment of vestibular schwannoma cells with ErbB inhibitors. Bush ML; Burns SS; Oblinger J; Davletova S; Chang LS; Welling DB; Jacob A Otol Neurotol; 2012 Feb; 33(2):244-57. PubMed ID: 22222570 [TBL] [Abstract][Full Text] [Related]
9. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas. Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697 [TBL] [Abstract][Full Text] [Related]
10. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay. Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848 [TBL] [Abstract][Full Text] [Related]
11. ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Ammoun S; Cunliffe CH; Allen JC; Chiriboga L; Giancotti FG; Zagzag D; Hanemann CO; Karajannis MA Neuro Oncol; 2010 Aug; 12(8):834-43. PubMed ID: 20511180 [TBL] [Abstract][Full Text] [Related]
12. The molecular biology and novel treatments of vestibular schwannomas. Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959 [TBL] [Abstract][Full Text] [Related]
13. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China. Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976 [TBL] [Abstract][Full Text] [Related]
14. Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells. Dilwali S; Roberts D; Stankovic KM Cancer Biol Ther; 2015; 16(1):170-5. PubMed ID: 25692621 [TBL] [Abstract][Full Text] [Related]
15. CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas. Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T Otol Neurotol; 2020 Jan; 41(1):e94-e102. PubMed ID: 31789805 [TBL] [Abstract][Full Text] [Related]
16. Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801. Dougherty MC; Shibata SB; Clark JJ; Canady FJ; Yates CW; Hansen MR J Neurosurg; 2023 Apr; 138(4):962-971. PubMed ID: 36087315 [TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen and progesterone receptors in vestibular schwannomas. Ilyalov SR; Ryzhova MV; Galkin MV; Banov SM; Golanov AV; Usachev DY Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(1):44-48. PubMed ID: 36763552 [TBL] [Abstract][Full Text] [Related]
18. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations. Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708 [TBL] [Abstract][Full Text] [Related]
19. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation. Hansen MR; Roehm PC; Chatterjee P; Green SH Glia; 2006 Apr; 53(6):593-600. PubMed ID: 16432850 [TBL] [Abstract][Full Text] [Related]
20. Immunoblotting analysis of schwannomin/merlin in human schwannomas. Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]